At-home urine estrone-3-glucuronide quantification predicts oocyte retrieval outcomes comparably with serum estradiol
- PMID: 36959966
- PMCID: PMC10028475
- DOI: 10.1016/j.xfre.2023.01.006
At-home urine estrone-3-glucuronide quantification predicts oocyte retrieval outcomes comparably with serum estradiol
Abstract
Objective: To investigate the feasibility of monitoring urine estrone-3-glucuronide (E3G) with an at-home device during gonadotropin stimulation for in vitro fertilization and oocyte cryopreservation.
Design: Prospective, observational cohort study.
Setting: Private fertility clinic.
Patients: Thirty patients undergoing stimulation with a gonadotropin-releasing hormone antagonist protocol for in vitro fertilization or oocyte cryopreservation.
Interventions: Daily collection of the first urine in the morning during stimulation and analysis performed at home by each patient with the Mira Fertility Tracker.
Main outcome measures: Primary outcomes were correlation of urine E3G and serum estradiol (E2) concentrations on the day of trigger to the number of total and metaphase 2 oocytes (MII). Secondary outcomes of interest were the correlation of matched E3G and E2 measurements and the daily trends of E3G and E2 during stimulation.
Results: Both urine E3G and serum E2 concentrations on the day of trigger significantly correlated with retrieval outcomes to a similar extent, with E3G demonstrating slightly higher correlation to the number of MII oocytes than that demonstrated by E2 (r = 0.485 vs. 0.391, respectively). The Pearson correlation coefficient for matched E3G and E2 levels was 0.761. The correlation coefficients of determination for daily trends of E3G and E2 during stimulation were 0.7066 and 0.6102, respectively.
Conclusions: Measured on the day of trigger, urine E3G monitoring during gonadotropin stimulation was comparable with serum E2 for predicting oocyte retrieval outcomes. Matched daily samples confirmed good correlation of urine E3G and serum E2. The option of at-home estrogen monitoring with devices such as Mira offers an alternative to traditional serum monitoring that may improve patient experience.
Clinical trial registration number: NCT05493202.
Keywords: Home urine test; IVF; estrone-3-glucuronide; immunoassay; telehealth.
© 2023 The Author(s).
Figures
Similar articles
-
The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation.Hum Reprod. 2020 May 1;35(5):1054-1060. doi: 10.1093/humrep/deaa042. Hum Reprod. 2020. PMID: 32406915
-
Estrone 3-glucuronide chemiluminescence immunoassay (LIA) and 17beta estradiol radioimmunoassay (RIA) in the monitoring of superovulation for in vitro fertilization (IVF): correlation with follicular parameters and oocyte maturity.Acta Eur Fertil. 1992 Mar-Apr;23(2):63-8. Acta Eur Fertil. 1992. PMID: 1338258
-
Algorithms with Area under the Curve for Daily Urinary Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide to Signal the Transition to the Luteal Phase.Medicina (Kaunas). 2022 Jan 13;58(1):119. doi: 10.3390/medicina58010119. Medicina (Kaunas). 2022. PMID: 35056427 Free PMC article.
-
Immunochemical tests of potential fertility.Biochem Soc Trans. 1992 Feb;20(1):234-7. doi: 10.1042/bst0200234. Biochem Soc Trans. 1992. PMID: 1633952 Review.
-
Ovarian stimulation for freeze-all IVF cycles: a systematic review.Hum Reprod Update. 2020 Jan 1;26(1):118-135. doi: 10.1093/humupd/dmz037. Hum Reprod Update. 2020. PMID: 31867625
Cited by
-
Insights into Perimenopause: A Survey of Perceptions, Opinions on Treatment, and Potential Approaches.Women (Basel). 2025 Mar;5(1):4. doi: 10.3390/women5010004. Epub 2025 Jan 31. Women (Basel). 2025. PMID: 40264725 Free PMC article.
-
Current Ovulation and Luteal Phase Tracking Methods and Technologies for Fertility and Family Planning: A Review.Semin Reprod Med. 2024 Jun;42(2):100-111. doi: 10.1055/s-0044-1791190. Epub 2024 Sep 20. Semin Reprod Med. 2024. PMID: 39303740 Free PMC article. Review.
-
A novel method for quantifying affective sensitivity to endogenous ovarian hormones.Psychoneuroendocrinology. 2024 Sep;167:107095. doi: 10.1016/j.psyneuen.2024.107095. Epub 2024 Jun 6. Psychoneuroendocrinology. 2024. PMID: 38896987
-
Understanding wrist skin temperature changes to hormone variations across the menstrual cycle.NPJ Womens Health. 2024;2(1):35. doi: 10.1038/s44294-024-00037-9. Epub 2024 Oct 4. NPJ Womens Health. 2024. PMID: 39372385 Free PMC article.
References
-
- Drakopoulos P., Blockeel C., Stoop D., Camus M., de Vos M., Tournaye H., et al. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31:370–376. - PubMed
-
- Garnett E., Bruno-Gaston J., Cao J., Zarutskie P., Devaraj S. The importance of estradiol measurement in patients undergoing in vitro fertilization. Clin Chim Acta. 2020;501:60–65. - PubMed
-
- Genuis S.J., Bouchard T.P. High-tech family planning: reproductive regulation through computerized fertility monitoring. Eur J Obstet Gynecol Reprod Biol. 2010;153:124–130. - PubMed
-
- Behre H.M., Kuhlage J., Gassner C., Sonntag B., Schem C., Schneider H.P., et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod. 2000;15:2478–2482. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical